Compound Detail
CHEMBL3099899
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3099899 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VDWKDBPHAPPUBO-UHFFFAOYSA-N |
9
Targets
19
Activities
2
Assay Types
4
PK Parameters
20
Publications
0
Known Names
Molecular Properties
494.4
MW (Da)
6.06
ALogP
5
HBA
1
HBD
73.3
PSA (Ų)
0.34
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 10 meas. best 7.92
Ki 9 meas. best 10.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Orexin receptor type 2 CHEMBL4792 | Ki | 10.15 | 10.15 | 0.1 | 1 |
| Orexin receptor type 2 CHEMBL4792 | IC50 | 7.92 | 7.92 | 12.0 | 1 |
| Orexin/Hypocretin receptor type 1 CHEMBL5113 | Ki | 7.03 | 7.03 | 94.5 | 1 |
| Orexin/Hypocretin receptor type 1 CHEMBL5113 | IC50 | 6.54 | 6.54 | 292.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.18 | 6.18 | 662.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.06 | 5.615 | 866.0 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 5.98 | 5.98 | 1040.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 5.88 | 5.88 | 1310.0 | 1 |
| Mu-type opioid receptor CHEMBL233 | Ki | 5.69 | 5.69 | 2040.0 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | Ki | 5.64 | 5.64 | 2280.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | IC50 | 5.64 | 5.64 | 2300.0 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | IC50 | 5.62 | 5.62 | 2400.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.6 | 5.345 | 2530.0 | 2 |
| D(3) dopamine receptor CHEMBL234 | Ki | 5.49 | 5.49 | 3240.0 | 1 |
| Mu-type opioid receptor CHEMBL233 | IC50 | 5.3 | 5.3 | 5020.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.16 | 5.16 | 6950.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 5.02 | 5.02 | 9540.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 4449.42 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 2300.0 | nM | Rattus norvegicus |
| Fu | 0.047 | - | Rattus norvegicus |
| Fu | 0.032 | - | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Unchecked | 203 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | 5-hydroxytryptamine receptor 1B | 6 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | 5-hydroxytryptamine receptor 1A | 6 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Mu-type opioid receptor | 6 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | D(3) dopamine receptor | 6 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | 5-hydroxytryptamine receptor 2B | 6 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Rattus norvegicus | 6 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 5 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Glutamate NMDA receptor | 3 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Voltage-gated L-type calcium channel | 3 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Insulin receptor | 2 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Plasma | 2 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Orexin/Hypocretin receptor type 1 | 2 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | GABA-A receptor; alpha-5/beta-3/gamma-2 | 2 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | GABA-A receptor; alpha-1/beta-3/gamma-2 | 2 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Orexin receptor type 2 | 2 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Thyrotropin-releasing hormone receptor | 1 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Sodium-dependent dopamine transporter | 1 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Sodium-dependent noradrenaline transporter | 1 |
| 24215892 | 10.1016/j.bmcl.2013.10.045 | Sodium-dependent serotonin transporter | 1 |
Data from ChEMBL 36 via Core Engine